JPMorgan trimmed its price target on Accenture (ACN) by $46, a notable cut against a company reporting $69.7B in revenue (+7.4% YoY) and $12.15 diluted EPS with an 11.0% net margin. The magnitude of the cut — without a rating downgrade — suggests JPMorgan still sees upside but at a lower base case, likely reflecting caution around enterprise discretionary IT budgets and macro softness heading into ACN's FY end in August 2025.

The setup hinges on whether the PT cut is a leading indicator of a broader analyst consensus reset or a one-off adjustment already absorbed by the market. Investors should watch for follow-on PT moves from other sell-side desks and ACN's next quarterly commentary on deal pipeline and bookings momentum, which historically drives the stock's re-rating cycles.